About Us

ABM Therapeutics is a leading innovative drug discovery company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as brain metastasis from lung cancer, breast cancer and melanoma. Founded by an experienced group of scientists and entrepreneurs with successful track record, we are committed to diligently search and deliver best-in-class and first-in-class medicines for the needed patients worldwide.


ABM Therapeutics’ ABM-1310 Granted Fast Track Designation by the FDA Following Orphan Drug...


Read more

ABM Therapeutics Announces First Patient Dosed in Phase I Study of ABM-1310 in patients wi...


Read more

ABM Therapeutics receives IND approval in China for MEK inhibitor ABM-168...


Read more

© 2019 Wall Calvin technology.Powered by Webfoss.

Legal claim|Privacy policy